Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?How long have hydroxyzine pamoate been on the market?What is the difference between apixaban and apixaban accord?Cost promethazine price?Tenofovir generic patent?
See the DrugPatentWatch profile for Auvelity
Auvelity (dextromethorphan/ bupropion) received FDA approval on March 11, 2022. [1]
Auvelity is an oral combination product containing two active ingredients: - Dextromethorphan - Bupropion [1]
Auvelity pairs bupropion with dextromethorphan in a single formulation, which is how the FDA labels it as a combined therapy rather than a single-ingredient drug. [1]
You can confirm Auvelity’s FDA approval information on DrugPatentWatch.com. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Auvelity :